Artes Medical Names Frank M. Fazio Vice President of Marketing; Medical Technology Company Appoints Seasoned Medical Marketing Executive to Senior Management Team.

SAN DIEGO -- Artes Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing a new category of permanent aesthetic injectable products, today announced the appointment of Frank M. Fazio to Vice President of Marketing.

"Frank has significant experience in launching innovative aesthetic products in the medical device and specialty pharma markets," said Dr. Stefan Lemperle, CEO of Artes Medical. "We believe he will be an exceptional leader in implementing our marketing campaigns for ArteFill. I look forward to working closely with Frank, and I am confident that his vision will help us convey Artes Medical's mission to our key physician and consumer audiences."

Mr. Fazio will report to Artes Medical's President and COO, Diane Goostree. Mr. Fazio's addition to the management team comes as the company awaits final FDA approval for its lead product, ArteFill(R), the first permanent aesthetic injectable implant for the correction of facial wrinkles known as nasolabial folds, or smile lines.

"I am thrilled to join Artes Medical as the company stands poised to introduce its first commercial product to the U.S. market," said Mr. Fazio. "To collaborate with Artes Medical's executive team and lead the marketing efforts targeted at physicians and consumers on a first-of-its-kind product is a wonderful opportunity."

Mr. Fazio has over 14 years experience in medical device and specialty pharmaceutical sales and marketing. Prior to joining Artes Medical, he most recently served as Director of Market Development for the Americas and Asia Pacific and as Director of Facial Aesthetics for North America at INAMED Corporation, a leading global healthcare company. Previously, Mr. Fazio held positions of increasing responsibility at Collagen Aesthetics (formerly known as Collagen Corporation), including Director of Sales Operations. Mr. Fazio received his Bachelor of Science in molecular and cellular biology from the University of Arizona.

About Artes Medical, Inc.

Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets. The Company's initial product candidate, ArteFill(R), is a permanent aesthetic injectable implant for the correction of facial wrinkles known as nasolabial folds, or smile lines.

Based in San Diego, CA, Artes Medical was founded in 1999 and is privately-held. Additional information about the Company and its products are available at www.artesmedical.com and www.artefill.com. Artes Medical and ArteFill are registered trademarks of Artes Medical, Inc.

Cautionary Statement

This news release contains forward-looking statements that are based on the Company's current beliefs and assumptions and on information currently available to its management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. As a result of these risks, uncertainties and other factors, readers are cautioned not to place undue reliance on any forward-looking statements included in this press release. These forward-looking statements represent beliefs and assumptions only as of the date of this news release, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.